Dry Eye Syndrome Treatment Market to Grow with a CAGR of 6.39% through 2030
The growing prevalence of dry eye syndrome is expected to
drive the growth of the global dry eye syndrome treatment market in the
forecast period,2026-2030.
According to TechSci Research report, “Dry Eye Syndrome
Treatment Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2030F”, the Global Dry Eye Syndrome Treatment Market was
valued at USD 6.31 Billion in 2024 and is expected to reach USD 9.15 Billion by
2030 with a CAGR of 6.39%. This can be ascribed to the increasing prevalence of
dry eye diseases along with the growing adoption of different treatments like
dry eye treatment drops and artificial tears for relieving different symptoms
across the globe. Similarly, the growing popularity of excimer and femtosecond
ophthalmic laser treatment for dry eye syndrome will further boost the market
growth over the years. Also, growing awareness regarding the diagnosis and
treatment of dry eye disease such as laser treatment among populations across
the globe will further propel the market growth. Additionally, growing demand
for better treatment outcomes and an increase in living standards especially in
the developed countries in North America and Europe is expected to create
lucrative opportunities for market growth in coming years. Besides, increasing
research and development activities in dry eye disease is further expected to
support the market growth. Similarly, rising the number of eye care
centers across the globe and rising penetration of OTC eyedrop in the
developing region will drive the market growth over the years.
However, due to lack of awareness regarding dry eye disease
and their treatment, people do not visit ophthalmologists regularly unless
there is any symptomatic condition. This can slow down the growth of global dry
eye syndrome treatment market in the forecast period. Similarly, high risks and
complications associated with dry eye treatment may hamper the dry eye syndrome
treatment market growth during the forecast period. Also, poor reimbursement
scenario and lack of insurance coverage for dry eye disease in emerging
countries can further restrict the growth of global dry eye syndrome treatment
market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Dry Eye Syndrome Treatment Market"
The Global Dry Eye Syndrome Treatment Market is
segmented into indication, product type, dosage form, type, distribution
channel, regional distribution, and company.
Based on Indication, the Aqueous Deficient Dry Eye Syndrome
(ADES) segment is also expected to witness fastest growth in the coming years,
driven by increasing prevalence and advancements in therapeutic technologies.
ADES occurs when the lacrimal glands fail to produce adequate aqueous tears,
often due to chronic inflammation or anatomical issues such as enlarged tear
ducts. This results in persistent dryness and ocular discomfort. Pharmaceutical
companies including I-Med Pharma, Novaliq GmbH, and Allergan are actively
engaged in developing and promoting specialized treatments targeting this
condition. With a growing global focus on eye health and greater public
education regarding dry eye diseases, the demand for ADES-specific treatments
is anticipated to rise significantly, paving the way for innovative therapies
and improved clinical outcomes.
Based on the Region, Asia Pacific exhibits the fastest
growth in the Global Dry Eye Syndrome Treatment Market. This rapid growth is
primarily fueled by a rising geriatric population, increasing urbanization, and
growing awareness about eye health across key countries such as China, India,
Japan, and South Korea. According to data from the United Nations Department of
Economic and Social Affairs (UNDESA), the population aged 60 and older in Asia
is projected to reach 1.3 billion by 2050, representing a substantial portion
of individuals at higher risk of developing dry eye syndrome due to age-related
ocular degeneration. In addition, environmental factors such as air pollution,
extended screen time, and changing climate conditions have contributed to the
increasing incidence of dry eye symptoms in the region. With more individuals
exposed to digital devices for work and leisure, the condition is becoming
increasingly common among younger demographics as well.
Major companies operating in the global dry eye syndrome
treatment market are:
- Johnson
& Johnson Services, Inc.
- AbbVie
Inc.
- Bausch
Health Companies Inc.
- Novartis
AG
- Sun
Pharmaceuticals Industries Limited
- Santen
Pharmaceutical Co., Ltd.
- Otsuka
Pharmaceutical Co., Ltd.
- Oyster
Point Pharma, Inc.
- Alcon
Inc.
- GlaxoSmithKline
plc
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“North America was expected to dominate in the global dry eye
syndrome treatment market on account due to the increasing geriatric population
are susceptible to different types of eye diseases, increasing development of
better healthcare for the treatment of dry eye diseases, and rising adoption of
new treatment across the region. Furthermore, the increasing prevalence of dry
eye disease and easy access to healthcare are further contributing to the
demand for the dry eye syndrome treatment market. Besides, the availability of
skilled professionals and early adoption of advanced treatments for the
treatment of different dry eye diseases in the region is further expected to
create lucrative opportunities for the market growth” said Mr. Karan Chechi,
Research Director of TechSci Research, a research based global management
consulting firm.
“Dry Eye Syndrome Treatment Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication
(Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Product
Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs,
Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye
Drops, Ointments), By Type (Prescription, Over The Counter), By Distribution
Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By
Region and Competition, 2020-2030F”, has evaluated the future growth
potential of global dry eye syndrome treatment market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global dry eye syndrome treatment market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com